Ignite Creation Date:
2024-05-06 @ 8:58 AM
Last Modification Date:
2024-10-26 @ 12:07 PM
Study NCT ID:
NCT02867891
Status:
COMPLETED
Last Update Posted:
2017-01-18
First Post:
2016-08-10
Brief Title:
Sorafenib In Relapse of FMS-like Tyrosine Kinase 3 FLT3-Internal Tandem Duplication ITD AML Trial
Sponsor:
Organization:
University of Freiburg
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITHOUT_DNA
Bio Spec Description:
Serum cytokine levels IL-15 IFN-gamma IL-6
Enrollment Count:
396
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 36506 |
Who Masked List: